Seeing Is Believing
Currently out of the existing stock ratings of Yanan Zhu, 104 are a BUY (75.36%), 34 are a HOLD (24.64%).
Analyst Yanan Zhu, currently employed at WELLS FARGO, carries an average stock price target met ratio of 42.46% that have a potential upside of 40.97% achieved within 98 days.
Yanan Zhu’s has documented 265 price targets and ratings displayed on 31 stocks. The coverage is on Healthcare, Technology sectors.
Most recent stock forecast was given on FATE, Fate Therapeutics at 13-Aug-2026.
Analyst best performing recommendations are on RGLS (REGULUS THERAPEUTICS).
The best stock recommendation documented was for QURE (UNIQURE NV) at 3/3/2026. The price target of $15 was fulfilled within 6 days with a profit of $5.97 (66.11%) receiving and performance score of 110.19.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 18-Jul-2023
$1185
$333.71 (39.20%)
$1185
Buy Since 16-Nov-2017
$1050
$198.71 (23.34%)
$1000
Hold Since 27-Feb-2026
$932
$80.71 (9.48%)
$867
Buy Since 25-Aug-2025
$1025
$173.71 (20.41%)
$945
Buy Since 26-Jul-2024
$1037
$185.71 (21.82%)
$1014
Which stock is Yanan Zhu is most bullish on?
Which stock is Yanan Zhu is most reserved on?
What Year was the first public recommendation made by Yanan Zhu?